Govt amends 2nd dose of Covishield to 4-8 weeks
March 22, 2021  15:34
image
This is from the ministry of health, government of India. Sit up and take note. 

The government now says that in view of emerging scientific evidence, interval between two doses of a specific COVID-19 vaccine i.e. Covishield, has been revisited by National Technical Advisory Group on Immunization and subsequently by National Expert Group on Vaccine Administration for COVID-19.

"Consequently, the recommendations has been revised to provide the 2nd dose of Covishield at 4-8 weeks' interval after the 1st dose, instead of the  earlier practiced interval of 4-6 weeks. This decision of revised time interval between two doses is applicable only to Covishield and not to Covaxin."

Covishield is the Covid-19 vaccine manufactured by the Serum Institute of India, while Covaxin is from Bharat Biotech. 
« Back to LIVE

TOP STORIES